Indonesia Diabetes Care Devices Market

Indonesia Diabetes Care Devices Market Overview

Indonesia Diabetes Care Devices Market size was valued at USD 150 million in 2025 and the market is projected to reach USD 264 million in 2033, growing at a CAGR of 7.3% during the forecast period from 2026-2033 due to growing prevalence of diabetes, increasing health awareness and early diabetes diagnosis, rising disposable incomes and an expanding middle-class population, as well as a growing aging population and the increasing prevalence of lifestyle-related diseases.

Market Size & Forecast:

• • 2025 – USD 150 Million
  • 2033 – USD 264 Million
  • Market Forecast – CAGR of 7.3% from 2026-2033

Key Segment Insights:

• • Product Type Insights: Insulin delivery devices segment dominates the market revenue in 2025
  • End-User Insights: Clinics hold the largest share of the diabetes care devices market in 2025.

Indonesia Diabetes Care Devices Market Growth Drivers

Growing Prevalence of Diabetes

Indonesia has one of the world’s largest diabetic populations, with approximately 20.4 million adults living with diabetes, ranking fifth globally among adults aged 20–79 years as per International Diabetes Federation (IDF). By 2050 the diabetic population is projected to reach 28.6 million an increase of 40% between 2024 and 2050. The continuous growth of diabetes patients in Indonesia is creating continuous robust demand for diabetic care devices in the country.

Growing Health Awareness and Early Diagnosis

The Indonesian government has intensified its efforts to address the growing diabetes burden through preventive, diagnostic, and treatment-focused initiatives. As part of these efforts, healthcare infrastructure is being expanded, particularly in underserved and rural areas, while community health centers (Puskesmas) are being equipped with diagnostic tools such as blood glucose monitors. These measures are improving early detection, disease management, and access to diabetes care, thereby supporting demand for diabetes monitoring devices across the country.

Aging Population and Changing Lifestyle

Indonesia is undergoing a demographic shift toward an aging population. As per BPS, the share of elderly individuals increased from 9.78% in 2020 to 11.75% in 2023 (around 32 million people) and is projected to exceed 14% by 2030, marking Indonesia’s transition into an aging society and increasing demand for healthcare services and chronic disease management. The aging trend is expected to further accelerate, with the number of individuals aged 60 and above projected to reach 63 million by 2045, representing approximately 20% of Indonesia’s population.

The adoption of modern lifestyle, especially among the Indonesian middle class and the rising country’s aging population, are the significant factors that are surging the number of diabetes patients, thus boosting the market growth. Modern lifestyle corresponds to a higher amount of calorie intake and sedentary behavior, which in turn, has increased in the number of people who are spending hours in front of the television, using mobile phones.

While diabetes has traditionally been more prevalent among individuals aged 60 and above, lifestyle changes are leading to a growing incidence among younger age groups. Consequently, the majority of diabetes cases in Indonesia are classified as Type 2 diabetes, driven by urbanization, unhealthy diets, increasing life expectancy, obesity, high carbohydrate intake, and sedentary lifestyles.

Challenges Faced by Indonesia Diabetes Care Devices Companies

Despite ongoing improvements in diabetes care, the availability and affordability of insulin and self-monitoring blood glucose (SMBG) devices remain key challenges in Indonesia, highlighting the need for comprehensive and coordinated policy interventions.

Indonesia Diabetes Care Devices Market Segment Analysis

Product Type Market Insights: Insulin delivery devices segment dominates the market revenue in 2025

Insulin delivery device segment captures the largest market share in 2025 and the segment is expected to grow at a robust CAGR during the forecast period. This is mainly due to the increasing adoption of insulin delivery devices among healthcare professionals and patients as they offer various exceptional benefits such as high stability and numerous technological advanced properties. On the other hand, the blood glucose monitoring devices segment is projected to lead the market during the forecast period. This is attributed to the strong demand for advanced diabetes care devices as it offers accurate measurement of the glucose level and gives a warning if the glucose level goes too high or too high.

Cost considerations and reimbursement coverage under BPJS Kesehatan (Indonesia’s national health insurance program) have resulted in basic finger-prick blood glucose monitoring devices and disposable insulin pen needles accounting for the majority of unit sales in the market.

End-User Market Insights: Clinics hold the largest share of the diabetes care devices market in 2025.

Clinics account for the largest share of the diabetes care devices market, supported by Indonesia’s universal healthcare system and the extensive network of government-funded primary healthcare facilities. Puskesmas provide subsidized or free blood glucose testing under BPJS Kesehatan, while Posbindu community health posts support large-scale screening and early detection of diabetes among at-risk populations.

Home care settings segment is projected to grow at the highest growth rate during the forecast period. This is mainly due to its user-friendly feature and affordable price range. Individuals have significantly shifted towards the usage of diabetes care devices at home rather than going to clinics or healthcare centers for regular health check-ups. Furthermore, the continuous technological advancement in these devices and the rising number of R&D activities to make the devices more user-friendly will further open new opportunities for the growth of the segment.

Indonesia Diabetes Care Devices Market Major Players & Competitive Landscape

Several leading companies operating in Indonesia diabetes care devices market are Medtronic, Novo Nordisk, Abbott, Roche, Tandem, Sanofi, Insulet, Medtronic and many more.

Indonesia’s diabetes care devices market presents substantial growth opportunities, particularly for manufacturers and distributors. Success in this evolving market will depend on effectively navigating regulatory developments, expanding access to innovative diabetes management solutions, and aligning strategies with the country’s healthcare priorities and national diabetes control initiatives. Opportunities for medical device companies within Indonesia’s diabetes care devices segment are highlighted across this producer-driven value chain. The market is already supported by the presence of leading global manufacturers from Europe and USA reflecting its attractiveness and growth potential.

Indonesia Diabetes Care Devices Market Scope of the Report

Indonesia Diabetes Care Devices Market Research Report Segmentation

The Indonesia Diabetes Care Devices market has been segmented on the basis of product type, end-user. Based on the product type, the market is segmented into blood glucose monitoring device and insulin delivery device. Based on the end-user, the market is segmented into homecare settings, hospitals, and others. The other segment is further segmented into clinics and ambulatory surgical centers.

Indonesia Diabetes Care Devices market by Product Type

• • Blood Glucose Monitoring Device
  • Insulin Delivery Device

Indonesia Diabetes Care Devices market by End-User

• • Hospitals
  • Homecare Setting
  • Others

 Indonesia Diabetes Care Devices Market Leading players

• • Novo Nordisk

  • Abbott

  • Roche

  • Tandem Diabetes Care

  • Sanofi

  • Insulet